Home | Welcome to Contract Pharma   
Last Updated Wednesday, January 28 2015

Print

Search Results for 'biopharma'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

By Gil Y. Roth
Published October 8, 2009
Amgen and SAFC discuss supply chain safety Read More »
By Eric S. Langer
Published October 8, 2009
10 Years of Bio-Outsourcing Read More »
By Steve Snyder
Published October 8, 2009
Where we've been and where we're going Read More »
By Michael A. Martorelli
Published October 8, 2009
A 10th anniversary perspective Read More »
By Gil Y. Roth
Published October 8, 2009
Our first decade is in the books Read More »
Published September 21, 2009
DOR BioPharma has been awarded a $9.4 million grant from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH). Read More »
By Eric S. Langer
Published September 3, 2009
Bio-Manufacturing Outsourcing Trends A funding crunch in biotech creates an outsourcing dilemma By Eric S. Langer The current funding crunch has put the brakes on some new R&D projects, and slowed the development of others in the p… Read More »
Building Agility into Pharma and Biopharma
By Chris Driscoll
Published September 3, 2009
Learning lessons from other industries Read More »
By Gil Y. Roth
Published September 3, 2009
I've done a bang-up job of staying out of this summer's rancorous "debates" over healthcare reform, and plan to stay on that path. So don't try to get me wound up. The thing is, I don't doubt the sincerity of citizens on both sides of the is… Read More »
Published August 12, 2009
Mark D. Young, Ph.D. has been named senior vice president of Pharmaceutical Operations at Alder Biopharmaceuticals Read More »
03 Novo Nordisk
Published July 23, 2009
#3 Novo Nordisk Novo Allé, 2880 Bagsværd, Denmark Tel: (45) 4444-8888 Fax: (45) 4449-0555 www.novonordisk.com Headcount 27,000   Year Established 1989  … Read More »
08 Roche
Published July 22, 2009
#8 Roche Grenzacherstrasse 124, CH-4070 Basel, Switzerland Tel: (41) 61 688 1111 Fax: (41) 61 691 9391 www.roche.com Headcount 80,080   Year Established 1896  … Read More »
04 Merck Serono
Published July 16, 2009
#4 Merck Serono Frankfurter Str. 250, D-64293 Darmstadt Germany Tel: (49) 6151-72-0 Fax: (49) 6151-72-2000 www.merck.de Headcount 32,800   Year Established 1668  … Read More »
11 Wyeth
Published July 16, 2009
#11 Wyeth Five Giralda Farms, Madison, NJ 07940 Tel: (973) 660-5000 Fax: (973) 660-7026 www.wyeth.com Headcount 47,426   Year Established 1926   Pharma Reve… Read More »
10 Bristol-Myers Squibb
Published July 16, 2009
#10 Bristol-Myers Squibb 345 Park Ave., New York, NY 10154-0037 Tel: (212) 546-4000 Fax: (212) 546-4020 www.bms.com Headcount 35,000   Year Established 1887  … Read More »
By Gil Roth
Published July 15, 2009
How do we keep up with the changing times? Read More »
2009 Top 10 Biopharmaceutical Companies Report
Published July 15, 2009
This edition of the Top 10 Biopharmas marks the end of an era. After this year, we’ll no longer be able to pencil in Amgen as our #1 biopharma, since Roche is poised to take that slot. A lot of major pharmas have talked about “becoming a global biopharma. Read More »
2009 Top 20 Pharmaceutical Companies Report
Published July 15, 2009
They don’t call them “Big Pharma” for nothing! Several of the industry’s biggest players decided to get bigger via M&A this year, which means next year’s ranks are going to feature at least three new players, once Wyeth and Schering-Plough are swallowed up and Roche moves over to the Top Biopharma ranks. And I do mean top! Read More »
01 Amgen
Published July 15, 2009
#1 Amgen One Amgen Center Dr., Thousand Oaks, CA 91320-1799 Tel: (805) 447-1000 Fax: (805) 447-1010 www.amgen.com Headcount 17,000   Year Established 1980  … Read More »
02 Genentech
Published July 9, 2009
#2 Genentech 1 DNA Way, South San Francisco, CA 94080 Tel: (650) 225-1000 Fax: (650) 225-6000 www.gene.com Headcount 11,000   Year Established 1976   Biopha… Read More »
01 Pfizer
Published July 9, 2009
#1 - Pfizer 235 E. 42nd St. New York, NY 10017-5755 Tel: (212) 573-2323 Fax: (212) 573-7851 www.pfizer.com Headcount 81,800   Year Established 2000   Phar… Read More »
06 Biogen Idec
Published July 8, 2009
#6 Biogen Idec 14 Cambridge Center, Cambridge, MA 02142 Tel: (617) 679-2000 Fax: (617) 679-2617 www.biogenidec.com Headcount 4,700   Year Established 2003  … Read More »
03 GlaxoSmithKline
Published July 8, 2009
#3 GSK 980 Great West Rd. Brentford, Middlesex TW8 9GS, UK Tel: (44) 020 8047 5000 Fax: (44) 020 8047 7807 www.gsk.com Headcount 99,003   Year Established 2002  … Read More »
Clinical Trial Imaging
By Kristin Brooks
Published June 3, 2009
Innovation, trends and challenges Read More »
CRO Industry Update
By Kristin Brooks
Published June 3, 2009
Opportunities in uncertain times Read More »
By Dave Jensen
Published June 3, 2009
Say what you mean Read More »
2009 Annual Outsourcing Survey
By Gil Roth, Editor
Published May 15, 2009
Welcome to our 5th Annual Contract Pharma Outsourcing Survey! More than 175 sponsor-side respondents offered up their opinions on outsourcing trends for this year's poll. Here's a breakdown of respondents by company type: Read More »
2009 Annual Outsourcing Survey
By Gil Roth
Published May 5, 2009
window.location="http://www.contractpharma.com/contents/view_outsourcing-survey/2009-05-15/2009-annual-outsourcing-survey-561099/"… Read More »
Also in This Issue
By Gil Roth
Published May 4, 2009
More features and columns in our print edition Read More »
By Ed Silverman
Published May 4, 2009
Follow-on biologics are on their way Read More »
Capacity Utilization & Capacity Constraints
By Eric S. Langer
Published May 4, 2009
Trends and differences in the U.S. & Western Europe Read More »
Biopharma CMO Market Report
By William Downey
Published May 1, 2009
Optimism remains high among bio-contract manufacturers Read More »
Mitigating Risk in the Biomaterial Cold Chain
By Jeff Clark
Published May 1, 2009
Cold chain management is essential in biopharma development Read More »
Published April 27, 2009
Novozymes Biopharma has begun construction of a new cGMP facility at its existing site in Tianjin, China, enabling the company to produce Bacillus-based Hyaluronic Acid (bHA), HyaCare, for the bio-medical and pharmaceutical industries. Read More »
Also in this issue
By Gil Roth
Published April 2, 2009
More features and columns in our print edition Read More »
By Gil Roth
Published April 1, 2009
With bio-financing tight, can service providers find new models? Read More »
Published March 25, 2009
Dr. Suman Kathuria has been appointed vice president of quality, OSO BioPharmaceuticals Manufacturing, LLC. Read More »
Success in Partnerships
By Pedram Alaedini and Howard Kim
Published March 4, 2009
Success in Partnerships Read More »
By Ed Silverman
Published March 4, 2009
Our new columnist speculates on the Pfizer/Wyeth fallout Read More »
By Gil Roth
Published January 22, 2009
Short takes on the world at large Read More »
Published January 22, 2009
Rick Lapointe has been appointed vice president of technology and acquisitions at OSO BioPharmaceuticals Manufacturing. Mr. Lapointe will be responsible for working with the senior leadership team to increase the company’s capabilities, identif… Read More »
By Steve Snyder
Published November 6, 2008
A look back at 2008 Read More »
By Eric S. Langer
Published November 6, 2008
Bio News & Views: Bio-Outsourcing Trends A new study explores capacity and production issues By Eric S. Langer Outsourcing biopharmaceutical production has become increasingly common during the past decade, with more than half of… Read More »
Vaccine Viewpoint
By Gil Roth
Published November 6, 2008
Michael Kowolenko of Wyeth talks about the convergence of vaccines and biotech Read More »
API Risk Communication Case History
By Jim Lieberman, CIH
Published November 6, 2008
Building a potent compound matrix to communicate with CMOs Read More »
By Kevin O'Donnell
Published October 3, 2008
More than just packing peanuts Read More »
By Michael Martorelli
Published October 3, 2008
Working together is a good idea Read More »
USP Changes
By John Daniels
Published October 3, 2008
Are you ready? Read More »
By Kevin O'Donnell
Published September 4, 2008
Additional risk to time- and temperature-sensitive freight? Read More »
Published August 20, 2008
Bristol-Myers Squibb and PDL BioPharma, Inc. entered an agreement for the global development and commercialization of PDL’s anti-CS1 antibody, elotuzumab, currently in Phase I development for multiple myeloma.     Elotuzumab o… Read More »


Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On